Davide Chiasserini
TitleCited byYear
The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers
N Mattsson, U Andreasson, S Persson, H Arai, SD Batish, S Bernardini, ...
Alzheimer's & Dementia 7 (4), 386-395. e6, 2011
2982011
CSF biomarker variability in the Alzheimer's Association quality control program
N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ...
Alzheimer's & Dementia 9 (3), 251-261, 2013
2372013
Cerebrospinal fluid biomarkers in Parkinson disease
L Parnetti, A Castrioto, D Chiasserini, E Persichetti, N Tambasco, ...
Nature Reviews Neurology 9 (3), 131, 2013
1472013
Cerebrospinal fluid Tau/α‐synuclein ratio in Parkinson's disease and degenerative dementias
L Parnetti, D Chiasserini, G Bellomo, D Giannandrea, C De Carlo, ...
Movement Disorders 26 (8), 1428-1435, 2011
1272011
Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset
D Chiasserini, JRT van Weering, SR Piersma, TV Pham, A Malekzadeh, ...
Journal of proteomics 106, 191-204, 2014
1252014
A practical guide to immunoassay method validation
U Andreasson, A Perret-Liaudet, LJC van Waalwijk van Doorn, ...
Frontiers in neurology 6, 179, 2015
1182015
Cerebrospinal fluid lysosomal enzymes and alpha‐synuclein in Parkinson's disease
L Parnetti, D Chiasserini, E Persichetti, P Eusebi, S Varghese, ...
Movement Disorders 29 (8), 1019-1027, 2014
1162014
Mitochondria and the link between neuroinflammation and neurodegeneration
M Di Filippo, D Chiasserini, A Tozzi, B Picconi, P Calabresi
Journal of Alzheimer's Disease 20 (s2), S369-S379, 2010
1062010
Effects of central and peripheral inflammation on hippocampal synaptic plasticity
M Di Filippo, D Chiasserini, F Gardoni, B Viviani, A Tozzi, C GiampÓ, ...
Neurobiology of disease 52, 229-236, 2013
1052013
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
L Parnetti, L Farotti, P Eusebi, D Chiasserini, C De Carlo, D Giannandrea, ...
Frontiers in aging neuroscience 6, 53, 2014
852014
Performance of Aβ 1-40, Aβ 1-42, total tau, and phosphorylated tau as predictors of dementia in a cohort of patients with mild cognitive impairment
L Parnetti, D Chiasserini, P Eusebi, D Giannandrea, G Bellomo, ...
Journal of Alzheimer's Disease 29 (1), 229-238, 2012
852012
Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies
D Chiasserini, S Paciotti, P Eusebi, E Persichetti, A Tasegian, ...
Molecular neurodegeneration 10 (1), 15, 2015
562015
Lysosomal Dysfunction and α‐Synuclein Aggregation in Parkinson's Disease: Diagnostic Links
T Moors, S Paciotti, D Chiasserini, P Calabresi, L Parnetti, T Beccari, ...
Movement Disorders 31 (6), 791-801, 2016
502016
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease
KD van Dijk, E Persichetti, D Chiasserini, P Eusebi, T Beccari, P Calabresi, ...
Movement Disorders 28 (6), 747-754, 2013
462013
Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients
P Sarchielli, M Di Filippo, MV Ercolani, D Chiasserini, A Mattioni, ...
Neuroscience letters 435 (3), 223-228, 2008
442008
CSF levels of heart fatty acid binding protein are altered during early phases of Alzheimer's disease
D Chiasserini, L Parnetti, U Andreasson, H Zetterberg, D Giannandrea, ...
Journal of Alzheimer's Disease 22 (4), 1281-1288, 2010
412010
Longitudinal changes in CSF alpha‐synuclein species reflect Parkinson's disease progression
NK Majbour, NN Vaikath, P Eusebi, D Chiasserini, M Ardah, S Varghese, ...
Movement Disorders 31 (10), 1535-1542, 2016
382016
Diagnostic utility of cerebrospinal fluid α‐synuclein in Parkinson's disease: A systematic review and meta‐analysis
P Eusebi, D Giannandrea, L Biscetti, I Abraha, D Chiasserini, M Orso, ...
Movement Disorders 32 (10), 1389-1400, 2017
372017
CSF proteome analysis in multiple sclerosis patients by two‐dimensional electrophoresis
D Chiasserini, M Di Filippo, A Candeliere, F Susta, PL Orvietani, ...
European Journal of Neurology 15 (9), 998-1001, 2008
372008
Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis
M Di Filippo, A De Iure, C GiampÓ, D Chiasserini, A Tozzi, PL Orvietani, ...
Scientific reports 6, 20926, 2016
362016
The system can't perform the operation now. Try again later.
Articles 1–20